🟢 Veraxa Biotech is trading 8.5% up today after immediate appointment of Raju Willener as CFO

Veraxa Biotech is trading 8.5% up at $1.66 after announcing Raju Willener’s immediate CFO appointment on September 4, 2026.

• Willener brings more than 30 years of financial expertise and succeeds former CFO Carl von Halem.
• Coverage coincided with shares’ 10.87% gain on September 3; no separate major catalyst or market-reaction explanation was reported.
• The move is best attributed to the company-specific announcement, though the source does not explicitly establish causation; trading remains active during the open session.